首页> 外国专利> GLYCOPEPTIDE COMPOUNDS HAVING ACTIVITY OF RESISTING DRUG-RESISTANT BACTERIA, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

GLYCOPEPTIDE COMPOUNDS HAVING ACTIVITY OF RESISTING DRUG-RESISTANT BACTERIA, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

机译:具有抗药性细菌活性的糖肽化合物及其制备方法和应用

摘要

Disclosed are glycopeptide compounds having activity of resisting drug-resistant bacteria, conforming to glycopeptide compounds represented by general formula (I). The present invention also provides a preparation method for and an application of the glycopeptide compounds. Upon testing, compared with a second-generation glycopeptide drug oritavancin, the glycopeptide antibiotic compounds have higher inhibition activity on drug-resistant bacterial strains, especially MRSA or VRE. Further testing shows that most of the glycopeptide compounds have safety higher than that of oritavancin and can be prepared into drugs for treating or preventing diseases caused by various bacterial infections, such as skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema.
机译:公开了具有抗药性细菌活性的糖肽化合物,其与通式(I)表示的糖肽化合物一致。本发明还提供了糖肽化合物的制备方法和应用。经测试,与第二代糖肽药物奥利万星相比,糖肽类抗生素化合物对耐药细菌菌株,尤其是MRSA或VRE具有更高的抑制活性。进一步的测试表明,大多数糖肽化合物的安全性都比奥利万星高,可以制成用于治疗或预防由各种细菌感染引起的疾病的药物,例如皮肤和软组织感染,脑膜炎,败血症,肺炎,关节炎,腹膜炎,支气管炎和脓胸。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号